The Centre for Precision Health (CPH), formerly the Centre for Personalised and Precision Health (CPPH) was set up in late 2014, as the core for research in Personalised and Precision health in NUHS. The CPH believes that the future of medicine lies in an
individualised healthcare approach for patients based on their health conditions, needs, or the biology of the disease, followed by the delivery of the care that maximises health and cost-effectiveness while limiting toxicity and other adverse effects.
The CPH brings together omics analysis, bioinformatics, health services research, patient data analytics and clinical trials to exploit characteristics unique to Asian phenotypes for targeted diagnosis and treatment. Through this approach, the CPH targets to develop new methods of disease management and evaluation of effectiveness against the Ministry of Health’s five strategic areas of diseases, namely cancers; cardiovascular diseases; diabetes mellitus and other metabolic/endocrine conditions; infectious diseases; and neurological and sense disorders.
The CPH is responsible for developing the strategy for precision medicine in NUHS and serves as the contact point for precision medicine efforts at the national level and with other industry players. The core objectives of CPH are to strengthen strategic alliances with industry partners to implement precision medicine in NUHS and to provide advice for project management and administrative support for pilots leading to clinical implementation in specific disease areas where precision medicine may have an impact in the short-term.